IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BOLLI, NICCOLO'
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.109
AS - Asia 10.420
NA - Nord America 10.143
SA - Sud America 1.041
AF - Africa 292
OC - Oceania 184
Continente sconosciuto - Info sul continente non disponibili 29
Totale 36.218
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.775
DE - Germania 6.735
CN - Cina 3.744
SG - Singapore 2.628
IT - Italia 2.033
GB - Regno Unito 1.747
HK - Hong Kong 931
BR - Brasile 786
RU - Federazione Russa 683
VN - Vietnam 681
SE - Svezia 620
FR - Francia 522
IN - India 476
JP - Giappone 421
BD - Bangladesh 382
FI - Finlandia 300
IE - Irlanda 298
NL - Olanda 259
KR - Corea 251
CA - Canada 242
ID - Indonesia 226
ES - Italia 196
AU - Australia 173
DK - Danimarca 112
TR - Turchia 105
PL - Polonia 80
AR - Argentina 79
IQ - Iraq 77
CI - Costa d'Avorio 76
CH - Svizzera 71
UA - Ucraina 68
MX - Messico 67
AT - Austria 65
TW - Taiwan 64
EG - Egitto 61
BE - Belgio 53
PK - Pakistan 52
PH - Filippine 51
CZ - Repubblica Ceca 46
GR - Grecia 46
IR - Iran 43
ZA - Sudafrica 43
SA - Arabia Saudita 42
MY - Malesia 39
CO - Colombia 38
TH - Thailandia 36
RO - Romania 34
EC - Ecuador 33
IL - Israele 32
CL - Cile 29
EU - Europa 28
NO - Norvegia 28
MA - Marocco 27
VE - Venezuela 23
AZ - Azerbaigian 19
PE - Perù 19
UZ - Uzbekistan 18
KE - Kenya 17
PY - Paraguay 16
AE - Emirati Arabi Uniti 15
LT - Lituania 14
NG - Nigeria 14
PT - Portogallo 14
HU - Ungheria 13
JO - Giordania 13
AL - Albania 12
BG - Bulgaria 12
CR - Costa Rica 12
KZ - Kazakistan 11
NP - Nepal 11
NZ - Nuova Zelanda 11
TN - Tunisia 11
DZ - Algeria 10
HN - Honduras 9
HR - Croazia 8
SK - Slovacchia (Repubblica Slovacca) 8
UY - Uruguay 8
JM - Giamaica 7
LB - Libano 7
BO - Bolivia 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
LU - Lussemburgo 6
RS - Serbia 6
TT - Trinidad e Tobago 6
CY - Cipro 5
ET - Etiopia 5
KW - Kuwait 5
PA - Panama 5
QA - Qatar 5
SC - Seychelles 5
SN - Senegal 5
AM - Armenia 4
AO - Angola 4
GY - Guiana 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
PS - Palestinian Territory 4
BB - Barbados 3
GH - Ghana 3
Totale 36.167
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 5.695
Singapore 1.487
Southend 1.257
Ashburn 1.036
Dallas 748
Hong Kong 742
Beijing 572
San Jose 569
Milan 535
Chandler 500
Hanover 486
Fairfield 399
Council Bluffs 365
Houston 360
Seattle 310
Dublin 292
Wilmington 275
Princeton 257
Los Angeles 255
Hefei 228
Ann Arbor 219
New York 216
Woodbridge 190
Helsinki 189
Ho Chi Minh City 186
Hanoi 182
Jakarta 177
Nanjing 177
Lauterbourg 165
Guangzhou 164
Dearborn 162
Redwood City 155
Bengaluru 152
Shanghai 152
Cambridge 146
Tokyo 146
Santa Clara 139
Hangzhou 138
Buffalo 136
Rome 127
Moscow 117
Seoul 110
Des Moines 97
Columbus 93
São Paulo 90
Tianjin 86
The Dalles 83
Jinan 81
Abidjan 76
Shenyang 73
Chicago 72
Boardman 69
Munich 67
Nuremberg 66
Wuhan 66
Andover 56
Bologna 56
Phoenix 56
San Diego 56
Changsha 54
London 54
Cangzhou 51
Toronto 49
Berlin 48
Istanbul 48
Melbourne 48
Naples 43
Vienna 41
Atlanta 40
Shenzhen 40
Boston 39
Montreal 38
Warsaw 38
Washington 37
Zhengzhou 36
Hebei 35
Madrid 35
Taipei 35
Brooklyn 34
Paris 34
Rochester 34
Brussels 33
Eitensheim 33
Alexandria 32
Chengdu 32
Genoa 32
Hyderabad 32
Rio de Janeiro 32
Amsterdam 31
Lappeenranta 31
Nanchang 31
Turku 31
Central 30
Falls Church 30
Turin 30
Baghdad 28
Bangkok 27
Barcelona 27
Fremont 27
Fuzhou 27
Totale 22.643
Salva come PNG Salva come JPEG
Nome #
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias 983
Genomic classification and prognosis in acute myeloid leukemia 977
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 905
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 897
Early Relapse Risk in Newly Diagnosed Multiple Myeloma Patients Characterized by Next-Generation Sequencing 554
Mieloma Multiplo: biologia, criteri diagnostici e prognostici 448
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc(+) AML 438
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 430
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas 416
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression 403
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma 398
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups 388
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition 356
A Journey Through Myeloma Evolution : From the Normal Plasma Cell to Disease Complexity 351
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis 350
Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML 349
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma 345
Genomic patterns of progression in smoldering multiple myeloma 331
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome 328
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 316
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma 309
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 302
Corrigendum: Signatures of mutational processes in human cancer 299
A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma 295
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 293
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification 291
Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population: Analysis of the "Health and Anemia" Study 286
Processed pseudogenes acquired somatically during cancer development 281
Tumor protein D52 (TPD52): A novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI 280
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma 267
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort 266
A practical guide for mutational signature analysis in hematological malignancies 264
What Is New in the Treatment of Smoldering Multiple Myeloma? 256
Integration of Transcriptional and Mutational Data Simplifies the Stratification of Peripheral T-Cell Lymphoma 254
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol 253
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine 251
A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes 251
Genomic landscape and chronological reconstruction of driver events in multiple myeloma 251
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 248
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma 245
Biology of peripheral T cell lymphomas : not otherwise specified: is something finally happening? 244
Analysis of the genomic lanscape of multiple myeloma highlights novel candidate prognostic markers and disease subgroups 242
Peripheral T-Cell Lymphomas Not Otherwise Specified: Potential Novel Molecular Entities Based on Both Tumor and Microenvironment Cellular Components 234
Analysis of mutations and structural variants to redefine the genomic landscape of multiple myeloma and its clinical implications 233
GATA-3 Expression in Peripheral T-Cell Lymphomas (PTCL): Identification of a Cut-Off and Prognostic Value in PTCL-NOS Versus Others Hystotypes 229
Analysis of different biological factors in patients affected by peripheral T-cell lymphomas not otherwise specified: GATA-3 expression is associated to refractory disease and poor outcome 228
A targeted sequencing approach in multiple myeloma reveals a complex landscape of genomic lesions that has implications for prognosis 227
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers 225
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer 225
A novel in-house deep sequencing method for non-invasive disease monitoring in multiple myeloma patients 225
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma 223
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant 223
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML 223
Angioimmunoblastic T cell lymphoma : novel molecular insights by mutation profiling 219
Mytype targeted next generation sequencing assay for detection of igh translocations and copy number alterations in multiple myeloma 217
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia 216
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma 215
Whole Genome Sequencing Reveals Recurrent Structural Driver Events in Peripheral T-Cell Lymphomas Not Otherwise Specified 215
Revealing the Impact of Structural Variants in Multiple Myeloma 215
Bowel perforation from occult ileal involvement after diagnosis in a case of primary mediastinal large B-cell lymphoma 210
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines 208
Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma 207
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts 204
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 203
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years [Clinical relevance of clonal hematopoiesis in persons aged >= 80 years] 202
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles 200
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde 196
Recurrent histone mutations in T-cell acute lymphoblastic leukaemia 196
The apobec mutational activity in multiple myeloma: from diagnosis to cell lines 196
Transcriptomic analysis in multiple myeloma and primary plasma cell leukemia with t(11;14) reveals different expression patterns with biological implications in venetoclax sensitivity 196
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort 195
The genomic landscape of structural variations and complex events in multiple myeloma 194
Next-Generation Sequencing for Clinical Management of Multiple Myeloma : Ready for Prime Time? 194
Acute myeloid leukemia with mutated nucleophosmin (NPM1) : is it a distinct entity? 193
Differential and limited expression of mutant alleles in multiple myeloma 192
A rare biclonal Hairy Cell Leukemia disclosed by an integrated diagnostic approach : a case report 187
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 186
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy 185
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion 182
Heterogeneity of mutational processes in multiple myeloma 182
Timing the initiation of multiple myeloma 181
Cereblon enhancer methylation and IMiD resistance in multiple myeloma 181
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 178
The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach 177
Circulating biomarkers in familial cerebral cavernous malformation 177
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis 175
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies 175
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer 174
Moving from Cancer Burden to Cancer Genomics for Smoldering Myeloma : a Review 173
Whole Genome Sequencing of Unique Paired SMM/MGUS Progressing to MM Samples Reveals a Genomic Landscape with Diverse Evolutionary Pattern 173
Initial analysis of the phenotypic consequences of SF3B1 K700E mutation expression in vitro and in vivo 172
Mytype: A Capture Based Sequencing Approach to Detect Somatic Mutations, Copy Number Changes and IGH Translocations in Multiple Myeloma 171
Differential and Limited Expression of Mutant Alleles in Multiple Myeloma 171
The chronological order of copy number changes in hyperdiploid multiple myeloma patients 170
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities 170
Analysis of Mutational Signatures Suggest That Aid Has an Early and Driver Role in Multiple Myeloma 169
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 168
The Landscape of Structural Variant Signatures in Multiple Myeloma Identifies Distinct Disease Subgroups with Implications for Pathogenesis 168
A new case of myelodysplastic syndrome associated with t(3;3)(q21;q26) and inv(11)(p15q22) 167
Investigation of the biological and molecular relevance of NONO protein in multiple myeloma 166
Totale 27.247
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.457
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021421 0 0 0 0 0 0 0 0 0 0 206 215
2021/20223.242 234 246 196 262 278 256 311 255 336 275 180 413
2022/20232.609 295 213 162 310 279 407 158 180 244 63 157 141
2023/20245.810 125 188 106 151 361 230 866 732 399 771 938 943
2024/20256.966 876 870 704 715 351 317 307 588 314 430 551 943
2025/202611.753 1.091 1.050 1.463 1.051 1.046 827 1.329 633 1.215 858 1.190 0
Totale 37.364